Human Exceptionalism

Geron Abandons Embryonic Stem Cell Research!

This is huge. Geron, which has spent many years touting its embryonic stem cell program as the future of regenerative medicine, is abandoning the field.  From the Washington Post story:

The company doing the first government-approved test of embryonic stem cell therapy is discontinuing further stem cell work, a move with stark implications for a field offering hope of future medicines for conditions with inadequate or no current treatments.

And, there’s a bias penalty flag on the field!  Geron’s decision does not provide “stark implications” given the tremendous advances made in ethical stem cell research, such as adult, induced pluripotent stem cell, umbilical cord stem cell, direct reprogramming from one type of cell to another, etc.  Back to the story:

Geron Corp., a pioneer in stem cell research that has been testing a spinal cord injury treatment, said late Monday that it’s halting development of its stem cell programs to conserve funds. It is seeking partners to take on the programs’ assets and is laying off much of its staff…In a statement, the company said the decision to narrow its focus “was made after a strategic review of the costs, … timelines and clinical, manufacturing and regulatory complexities associated with the company’s research and clinical-stage assets.”

Gobbledygook.

I am sorry, but this momentous decision deserves far more attention than a relatively short story in the business section. The media has been utterly fawning in its promotion of embryonic stem cell research for more than ten years, and still often reports that it is the best hope for regenerative treatments, when that is clearly no longer true.  Indeed, the media has been so in the tank that it has often ignored far superior results from ethical approaches, as I have repeatedly detailed over the years.

That being so, Geron and the media have an obligation to explain the why of this story in some detail and without spin. Was it the recent European ruling banning the patenting of embryonic stem cell products (about which I wrote) a factor?  Was its human trial a disappointment?  If it is out of money, why aren’t venture capitalists more willing to invest more in the fielf if it is so promising? I am sure you all have questions of your own.

Like I said, the issuance of a terse, jargon filled statement and a folding of tents is unacceptable.  Time for the media to stop being suppine and dig into what actually happened here.

Most Popular

Immigration

Angela Rye Knows You’re Racist

The political philosopher Michael Oakeshott said that the “rationalist” is hopelessly lost in ideology, captivated by the world of self-contained coherence he has woven from strands of human experience. He concocts a narrative about narratives, a story about stories, and adheres to the “large outline which ... Read More
Immigration

What the Viral Border-Patrol Video Leaves Out

In an attempt to justify Alexandria Ocasio-Cortez’s absurd comparison of American detention facilities to Holocaust-era concentration camps, many figures within the media have shared a viral video clip of a legal hearing in which a Department of Justice attorney debates a panel of judges as to what constitutes ... Read More
Politics & Policy

Pro-Abortion Nonsense from John Irving

The novelist has put up a lot of easy targets in his New York Times op-ed. I am going to take aim at six of his points, starting with his strongest one. First: Irving asserts that abortion was legal in our country from Puritan times until the 1840s, at least before “quickening.” That’s an overstatement. ... Read More